Biotech Values

[puravida]

Horizon Therapeutics plc (Nasdaq: HZNP) and Viela Bio, Inc. (Nasdaq: VIE) today announced the companies have entered into a definitive agreement under which Horizon will acquire all of the issued and outstanding shares of Viela Bio, Inc. common stock for $53.00 per share in cash, which represents a fully diluted equity value of approximately $3.05 billion, or approximately $2.67 billion net of Viela's cash and cash equivalents

https://ir.horizontherapeutics.com/news-releases/news-release-details/horizon-therapeutics-plc-acquire-viela-bio-inc-significantly




We knew Horizon raised nearly a billion in $ for M&A. now we know why.